3409 results for «2023»
3409 results
Unmet clinical need & relevance of intermediate & XL sizes in TAVI
08 Jan 2024 – From PCR London Valves 2023
In this roundtable discussion, Patrick Serruys, Andreas Baumbach, and Christian Juhl Terkelsen explore the innovative concept of intermediate sizes and extra-large valves. They introduce a new valve which is another step forward in addressing the unmet needs of the interventional cardiovascular community.
This interview was filmed at...
EuroPCR 2025 – The place to share solutions
07 May 2025
The annual World-Leading Course in interventional cardiovascular medicine is the official meeting of the European Association for Percutaneous Cardiovascular Interventions (EAPCI). Thousands of participants will once again be gathering to share their knowledge, skills and experience on 20-23 May 2025, at the Palais des Congrès in...
EuroPCR 2025 – The FAITAVI trial: angiography versus physiology-guided PCI in patients undergoing TAVI – 12-month follow-up data
21 May 2025
Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...
What is the role of mechanical circulatory support in cardiogenic shock in patient with AMI?
17 May 2023 – From EuroPCR 2023
Shrilla Banerjee and Valeria Paradies were invited to talk about a subject that was very often raised during EuroPCR 2023: how to save both the patient and the myocardium in case of cardiogenic shock?
As there is currently little evidence of the benefits of mechanical circulatory assistance, which...
Advances in the management of bifurcation lesions
17 May 2023 – From EuroPCR 2023
Follow this conversation between Rony Mathew, Rishi Sethi and Ashok Seth at EuroPCR 2023 and learn more about advances in the management of bifurcation lesions.
At a time when the number of patients suffering from bifurcation lesions is constantly rising and represents a major challenge, take a closer...
DEFINE FLAIR 5-year and Reveal iFR: learnings on coronary physiology
18 May 2023 – From EuroPCR 2023
Javier Escaned invites Justin Davies and Patrick Serruys to give an update on two trials presented at EuroPCR 2023: DEFINE-FLAIR 5-year follow-up and Reveal iFR.
DEFINE-FLAIR was the largest physiological study of its kind at the time, testing iFR in a non-inferior setting against FFR. The data...
Multivessel disease, which patients for PCI, CABG or medical treatment?
17 May 2023 – From EuroPCR 2023
Because multivessel disease raises many challenges, cardiac surgeon Lenard Conradi and interventional cardiologist Davide Capodanno discuss the biggest ones.
Is invasive coronary angiography really necessary? If revascularisation is required, which patient should be given a PCI rather than a CABG, and vice versa? What is state-of-the-art in surgery in...
Mitral Late-Breaking Trials: CLASP IID, AltaValve transseptal programme, MitraSwiss in men and women, MiCLASP...
19 Nov 2023 – From PCR London Valves 2023
Discover the mitral late-breaking trials which were presented during PCR London Valves 2023:
- One-year outcomes of transcatheter mitral repair from the CLASP IID Registry
- AltaValve transseptal programme update
- Mitral TEER in men and women from MitraSwiss registry: is equality achieved?
- Combined impact of mitral valve gradients and mitral regurgitation reduction...
Tricuspid Late-Breaking Trials: TRISCEND at 2 years, TEER in primary tricuspid regurgitation, TriCLASP, bRIGHT...
19 Nov 2023 – From PCR London Valves 2023
Discover the tricuspid late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND study two-year outcomes: transfemoral TTVR
- Transcatheter edge-to-edge repair in patients with primary tricuspid regurgitation
- One-year outcomes of transcatheter tricuspid valve repair from the TriCLASP study
- TTVR with the LuX-Valve system: one-year outcomes of a multicentre experience
- Real-world...
Understanding how to use evidence in clinical practice
14 May 2024 – From EuroPCR 2024
This session focuses on understanding how to apply the latest evidence and clinical guidelines in daily practice for Non-Interventional Cardiologists (NAPs). It covers the influence of patient-reported outcomes on cardiovascular clinical practices, the translation of the 2023 ACS clinical guidelines into NAP's practice, the impact of...
Newer generation self-expanding platform: technical optimisation for common clinical challenges
05 Dec 2023 – From GulfPCR-GIM 2023
The primary focus of this GulfPCR-GIM 2023 session revolves around pre-procedural planning considerations, valve selection, and managing complex anatomies using both traditional self-expanding valves and the Evolut FX system. Additionally, the session aims to explore the work-up protocol for patients grappling with severe AS and advanced...
Essentials of lifetime management of TAVR patients using novel Myval THV
05 Dec 2023 – From GulfPCR-GIM 2023
Join this GulfPCR-GIM 2023 session to explore the Myval next-generation THV technology, uncovering its unique features, procedural advantages, and clinical benefits, from extensive patient data. Learn also about the CorAlign technique that ensures precise commissural and coronary alignment while preserving coronary access, and gain insights into...
TAVI - Patient selection
20 Nov 2023 – From PCR London Valves 2023
Gain essential insights into TAVI patient selection through these selected abstract submissions from PCR London Valves 2023: explore the benefits of guideline-directed therapy for severe aortic stenosis, unravel the significance of subthreshold aortic valve calcium scores in patients with cardiac amyloidosis and aortic stenosis, delve into...
The Top Late-Breaking Trials: TRISCEND II, TRILUMINATE at 3 years, EuroSMR score, CLASP IID, OPERA-TAVI...
19 Nov 2023 – From PCR London Valves 2023
Discover the top late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND II: A randomised trial of transcatheter tricuspid valve replacement vs medical therapy
- Percutaneous edge-to-edge repair for tricuspid regurgitation: TRILUMINATE trial three-year outcomes
- Transcatheter mitral valve-in-valve vs. redo surgical replacement for degenerated bioprostheses
- Artificial intelligence derived risk...
Lifetime management - Tailoring treatment options to secure future possibilities
07 Dec 2023 – From GulfPCR-GIM 2023
Discover key insights in this video session from GulfPCR-GIM 2023 focusing on post-TAVI considerations. Gain understanding into the importance of posterior left ventricular and conduction disorders after TAVI and their impact on long-term outcomes. Explore the latest evidence regarding lifetime management for aortic stenosis patients. Delve...
20 years of TEER: a journey at the crossroads of the human heart
20 Nov 2023 – From PCR London Valves 2023
In 2023, with 200,000 MitraClips performed, the session concluded by posing the question of how many M-TEERs would be conducted by 2026. While the answer remains a mystery until PCR LV 2026, explore the fascinating history of transcatheter edge-to-edge mitral valve repair in this session. Delve...
LAA closure - LIVE case
16 May 2024 – From EuroPCR 2024
A 78-year-old woman with hypertension, diabetes, obesity, and a history of pacemaker implantation in 2023, presented with retinal hemorrhage while on NACO for AF. Despite a CHA2DS2-VASC score of 5, anticoagulation was withdrawn. The operators implanted a Watchman device in the LAA via a venous right femoral...
Complex CTO - LIVE case
22 Sep 2023 – From AICT-AsiaPCR 2023
View the case of an 82-year-old man with history of CABG in 2003 (LIMA LAD, VG RCA, VG CX), PCIs on VG RCA in 2021, PCIs VG-CX in 2022, PPM in 2023 with preserved LV function, and follow the retrograde approach of calcified CX CTO using...
Transcatheter tricuspid valve interventions
17 May 2023 – From EuroPCR 2023
Consult this session if you want to understand clinical scenarios associated with tricuspid regurgitation, to learn the state of the art in devices and indications to treat tricuspid regurgitation, and to deepen into the available evidence of outcomes of different therapies for tricuspid regurgitation.
Open design, confident delivery - How a novel LAA closure device provides predictable outcomes in complex anatomical settings
16 Nov 2025 – From PCR London Valves 2025
This session highlights a novel left atrial appendage (LAA) closure device featuring an open-cage design that delivers predictable clinical and procedural outcomes. It discusses the device's advantages in managing complex anatomical variations and presents implantation techniques across diverse anatomies to improve safety and efficacy.
